Show
Sort by
-
- Journal Article
- A1
- open access
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
-
Belgian experience with direct acting antivirals in people who inject drugs
-
- Journal Article
- A1
- open access
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection
-
Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in Belgium : a sub-analysis of the PROPHESYS study
-
- Journal Article
- A1
- open access
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA
-
Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: a Meta-analysis of two large prospective clinical trials
-
- Journal Article
- A1
- open access
Response-guided telaprevir combination treatment for hepatitis C virus infection
-
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients
-
Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C
-
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection